Skip to main content

Eragen Signs up Aventis for Software License Renewal, Services

NEW YORK, July 15 -  EraGen Biosciences has signed up  Aventis for contract services and a renewal of a licensing agreement for the company's genomic-based software analysis system, EraGen said today.

 

Under the agreement,  Aventis will be able to access EraGen's technical support group for drug discovery using EraGen's Master Catalog software.

 

Master Catalog uses the evolutionary characteristics of 130 genomes, as well as Pathogenome, a proprietary database, for in silico prediction of proteins that are potential drug targets.

 

Eragen is based in Madison, Wis.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.